You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 3, MARCH 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

An Evaluation of the Quinolone-Theophylline Interaction Using the Food and Drug Administration Spontaneous Reporting System

Thaddeus H. Grasela, Jr, PharmD; Michael W. Dreis, RPh, MPH

Arch Intern Med. 1992;152(3):617-621.


Abstract

A review of the Food and Drug Administration's spontaneous reporting system identified 48 reports of adverse events in patients who received concomitant therapy with ciprofloxacin (n = 39) or norfloxacin (n = 9) and theophylline. The mean (SD) age of these cases was 68.4 (18.5) years; 25 patients (52%) were female. The mean percent change in theophylline concentrations was 114%, with a range of 32% to 308% following the addition of a quinolone to the patient's theophylline regimen. Fourteen (36%) of the 39 patients receiving ciprofloxacin and three (33%) of the nine patients receiving norfloxacin experienced a seizure. The accumulated evidence suggests that extreme caution should be used when quinolones are prescribed in conjunction with theophylline, particularly in elderly patients. Further research is required to identify risk factors that will more specifically predict the magnitude of the interaction.

(Arch Intern Med. 1992;152:617-621)



Author Affiliations

From the Center for Pharmacoepidemiology Research, State University of New York at Buffalo, School of Pharmacy (Dr Grasela), and Data Processing Section, Division of Epidemiology and Surveillance, Food and Drug Administration, Rockville, Md (Mr Dreis).


Footnotes

Accepted for publication September 27, 1991.

Reprint requests to Center for Pharmacoepidemiology Research, State University of New York at Buffalo, School of Pharmacy, 319 Cooke Hall, Buffalo, NY 14260 (Dr Grasela).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

PRIMAQUINE: REPORT FROM CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS I.
HILL et al.
Am J Trop Med Hyg 2006;75:402-415.
ABSTRACT | FULL TEXT  

Seizures and Epilepsy in the Elderly
Thomas
Arch Intern Med 1997;157:605-617.
ABSTRACT  

Adverse Drug Interactions Clinically Important for the Dermatologist
Andersen and Feingold
Arch Dermatol 1995;131:468-473.
ABSTRACT  

DRUG INTERACTION BETWEEN THEOPHYLLINE AND QUINOLONE ANTIBIOTICS
JWatch General 1992;1992:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.